At least 1,000 COVID-19 deaths linked to workplace transmission were reportedly never investigated

More than 1,000 worker deaths from COVID-19 that were linked to workplace transmission were never investigated by the Occupational Safety and Health Administration at the state or local level, a Wall Street Journal investigation found. The Journal notes that the number likely understates that actual toll.
Many of those fatalities weren't reported to OSHA agencies by employers in the first place, but David Michaels, the OSHA director in the Obama administration, told the Journal the coronavirus pandemic still "exposed OSHA's great weaknesses."
Indeed, the Journal reports, OSHA records and state health care data show the agencies often took limited steps when they did respond to safety complaints. For example, the Journal identified 180 COVID-19 deaths among workers that occurred four weeks or more after complaints to OSHA agencies. In those cases, the investigation didn't extend beyond corresponding with employers. And despite an increase in complaints during the pandemic, OSHA agencies actually conducted fewer inspections than they did in the previous year.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
But, aside from a lack of action, it seems there were also built-in inefficiencies that left the OSHA unprepared to respond to pandemic. The agency's rules, the Journal reports, are "designed to minimize chemical-exposure risks and injuries such as falls and electric shocks," not infectious disease. Officials did start drafting rules centered on preventing the spread of such diseases in healthcare facilities after the 2009 H1N1 flu pandemic, but never completed the process. Read more at The Wall Street Journal.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The Week contest: Amazon Bond
Puzzles and Quizzes
By The Week US Published
-
6 grand homes in Boulder
Feature Featuring a mountain-facing balcony in Lower Chautauqua and a clover-shaped home in Flagstaff
By The Week US Published
-
Why Serbian protesters set off smoke bombs in parliament
THE EXPLAINER Ongoing anti-corruption protests erupted into full view this week as Serbian protesters threw the country's legislature into chaos
By Rafi Schwartz, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published